Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

313 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Mechanism-based pharmacokinetic model for paclitaxel.
Henningsson A, Karlsson MO, Viganò L, Gianni L, Verweij J, Sparreboom A. Henningsson A, et al. Among authors: vigano l. J Clin Oncol. 2001 Oct 15;19(20):4065-73. doi: 10.1200/JCO.2001.19.20.4065. J Clin Oncol. 2001. PMID: 11600609 Clinical Trial.
Targeting TRAIL agonistic receptors for cancer therapy.
Carlo-Stella C, Lavazza C, Locatelli A, Viganò L, Gianni AM, Gianni L. Carlo-Stella C, et al. Among authors: vigano l. Clin Cancer Res. 2007 Apr 15;13(8):2313-7. doi: 10.1158/1078-0432.CCR-06-2774. Clin Cancer Res. 2007. PMID: 17438088 Review.
Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.
Pascucci L, Coccè V, Bonomi A, Ami D, Ceccarelli P, Ciusani E, Viganò L, Locatelli A, Sisto F, Doglia SM, Parati E, Bernardo ME, Muraca M, Alessandri G, Bondiolotti G, Pessina A. Pascucci L, et al. Among authors: vigano l. J Control Release. 2014 Oct 28;192:262-70. doi: 10.1016/j.jconrel.2014.07.042. Epub 2014 Jul 30. J Control Release. 2014. PMID: 25084218
Modulation of the Estrogen/erbB2 Receptors Cross-talk by CDK4/6 Inhibition Triggers Sustained Senescence in Estrogen Receptor- and ErbB2-positive Breast Cancer.
Viganò L, Locatelli A, Ulisse A, Galbardi B, Dugo M, Tosi D, Tacchetti C, Daniele T, Győrffy B, Sica L, Macchini M, Zambetti M, Zambelli S, Bianchini G, Gianni L. Viganò L, et al. Clin Cancer Res. 2022 May 13;28(10):2167-2179. doi: 10.1158/1078-0432.CCR-21-3185. Clin Cancer Res. 2022. PMID: 35254385 Free PMC article. Clinical Trial.
313 results